Stay current with the rapidly evolving landscape of thyroid cancer treatment. This concise, expert led session highlights the most important updates from the American Thyroid Association 2025 guidelines and brings them to life through practical, case-based discussion. Featured panelists include colleagues from Endocrinology, ENT Surgery, Endocrine Surgery, and Medical Oncology.

Featured Focus Areas:

  • Evolving surgical indications
  • Current recommendations for radioactive iodine therapy
  • Tyrosine kinase inhibitor (TKI) therapy: where it fits in today’s treatment algorithm

Register today and be part of the conversation shaping the future of thyroid cancer treatment.

Date:
Thursday, June 04, 2026
Start Time:
5:30 p.m. PDT
Host or Sponsor:
Fred Hutch Cancer Center
Location:
Virtual - Zoom
Speaker or Presenter:
Chairs: Emily Marchiano, MD and Mara Roth, MD
Cost:

Free

CME Accreditation

In support of improving patient care, The University of Washington School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Washington School of Medicine designates this live activity of a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.